INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 441m ago
HOUSE PTR41m ago
SEC 13F41m ago
ROBINHOOD CHAIN40m ago
Public company

USNAUSANA HEALTH SCIENCES INC

CIK 0000896264

EDGAR filingsOpen in network
Disclosed transactions47
Buys / sells0 / 3
Max Insider Score41
Connections10with evidence

USNA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2833 · Medicinal Chemicals & Botanical Products · Nov 4, 2026
  • ← Lobbied forevidence
    MICHAEL BEST STRATEGIES LLCLDA Q2 2026 second quarter · Labor, Consumer issues · Aug 26, 2026
  • ← Insider ofevidence
    Ding XiaDirector · Apr 27, 2026
  • ← Insider ofevidence
    Fleming John TurmanDirector · Apr 27, 2026
13
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F
$14K
935 sh
Oct 22, 2026
Oct 23, 2026
traded Oct 22, 2026
+1d
SEC FORM 4

Evidence

21
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

13
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

13
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$8,770
604 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

21
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

13
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

17
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

13
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

13
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

21
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

17
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,632 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

29
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Open-market sale
SELL$44K
2,450 sh
Jun 1, 2026Jun 1, 2026
traded Jun 1, 2026
+0dSEC FORM 4

Evidence

9
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
6,527 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

9
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
6,527 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

17
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

9
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

9
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$7,523
391 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$13K
668 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

9
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

9
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

9
DX
Ding XiaDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

13
FT
Fleming John TurmanDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,057 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

17
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
21.8K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC FORM 4

Evidence

21
AM
Armstrong Kathryn MichelleCHIEF SCIENTIFIC OFFICER
USNAUSANA HEALTH SCIENCES INC
Grant or award
A—
24.5K sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC FORM 4

Evidence

5
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
631 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

9
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,157 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

13
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$4,673
219 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

17
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,157 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

5
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

17
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$7,405
347 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

17
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
631 sh
Feb 7, 2026Feb 10, 2026
traded Feb 7, 2026
+3dSEC FORM 4

Evidence

13
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$8,557
401 sh
Feb 8, 2026Feb 10, 2026
traded Feb 8, 2026
+2dSEC FORM 4

Evidence

5
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,000 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

13
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

13
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
WJ
Winssinger Frederic JDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
NS
Nixon J ScottDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

17
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Option exercise
M—
1,058 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

13
PP
Pelosi PeggieDirector
USNAUSANA HEALTH SCIENCES INC
Tax withholding
F$15K
669 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

30
MM
Mulham David MulhamCHIEF SALES OFFICER
USNAUSANA HEALTH SCIENCES INC
Open-market sale
SELL$18K
873 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

41
BP
Benedict PeterCHIEF INFORMATION OFFICER
USNAUSANA HEALTH SCIENCES INC
Open-market sale
SELL$56K
2,673 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Armstrong Kathryn MichelleCHIEF SCIENTIFIC OFFICER · Feb 23, 2026
  • ← Insider ofevidence
    Nixon J ScottDirector · Jan 26, 2026
  • ← Insider ofevidence
    Winssinger Frederic JDirector · Jan 26, 2026
  • ← Insider ofevidence
    Pelosi PeggieDirector · Jan 26, 2026
  • ← Insider ofevidence
    Benedict PeterCHIEF INFORMATION OFFICER · Dec 11, 2025
  • ← Insider ofevidence
    Mulham David MulhamCHIEF SALES OFFICER · Dec 11, 2025

    • Lobbying

    $40K reported · de-duplicated
    2026 Q2 $20K via firms2026 Q1 $20K via firms
    • MICHAEL BEST STRATEGIES LLC$20K2026 Q1 · posted Aug 26, 2026 · Telecommunications, Labor
    • MICHAEL BEST STRATEGIES LLC$20K2026 Q2 · posted Aug 26, 2026 · Labor, Consumer issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.